Here’s what you should know:
1. Boston Scientific had $2.41 billion in sales for the fourth quarter of 2017, which is an increase from 2016’s $2.19 billion in sales.
2. Boston Scientific increased full year sales from $8.39 billion in 2016 to $9.05 billion in 2017.
3. The company’s cardiovascular segment was its sales leader, accounting for $3.5 billion in total sales for 2017.
4. Boston Scientific will discuss its fourth quarter and full year sales Feb. 1.
More articles on supply chain:
FDA grants IlluminOss marketing clearance for bone stabilization system
Allscripts to acquire Practice Fusion for $100M: 5 things to know
McKesson completes $735M acquisition of CrossroadsRx: 4 things to know
